Column Group
Latest statistics and disclosures from Column Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ORIC, Surrozen, TNYA, Rapt Therapeutics, RVMD, and represent 100.00% of Column Group's stock portfolio.
- Reduced shares in these 1 stock: Rapt Therapeutics (-$30M).
- Column Group was a net seller of stock by $-30M.
- Column Group has $81M in assets under management (AUM), dropping by 23.19%.
- Central Index Key (CIK): 0001833486
Tip: Access up to 7 years of quarterly data
Positions held by Column Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Column Group
Column Group holds 5 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Oric Pharmaceuticals (ORIC) | 52.5 | $43M | 3.5M | 12.00 |
|
|
| Surrozen | 23.9 | $19M | 1.5M | 12.89 |
|
|
| Tenaya Therapeutics (TNYA) | 18.3 | $15M | 9.4M | 1.58 |
|
|
| Rapt Therapeutics | 5.3 | $4.3M | -87% | 166k | 25.79 |
|
| Revolution Medicines (RVMD) | 0.0 | $2.1k | 46.00 | 46.70 |
|
Past Filings by Column Group
SEC 13F filings are viewable for Column Group going back to 2020
- Column Group 2025 Q3 filed Nov. 14, 2025
- Column Group 2025 Q2 filed Aug. 15, 2025
- Column Group 2025 Q1 filed May 14, 2025
- Column Group 2024 Q4 filed Feb. 14, 2025
- Column Group 2024 Q3 filed Nov. 14, 2024
- Column Group 2024 Q2 filed Aug. 15, 2024
- Column Group 2024 Q1 filed May 15, 2024
- Column Group 2023 Q4 filed Feb. 9, 2024
- Column Group 2023 Q3 filed Nov. 13, 2023
- Column Group 2023 Q2 filed July 24, 2023
- Column Group 2023 Q1 filed May 15, 2023
- Column Group 2022 Q4 filed Feb. 13, 2023
- Column Group 2022 Q3 filed Nov. 14, 2022
- Column Group 2022 Q2 filed Aug. 12, 2022
- Column Group 2022 Q1 filed May 16, 2022
- Column Group 2021 Q4 filed Feb. 11, 2022